miR-638 suppresses cell proliferation in gastric cancer by targeting Sp2

Digestive Diseases and Sciences

Volumn 59, Issue 8, 2014, Pages 1743-1753

  Zhao, Ling Yu ^a   Yao, Yu ^b   Han, Jia ^a   Yang, Juan ^a   Wang, Xiao Fei ^a   Tong, Dong Dong ^a   Song, Tu Sheng ^a   Huang, Chen ^a   Shao, Yuan ^b  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

Author keywords

Gastric cancer; miR 638; Proliferation; Sp2

Indexed keywords

CYCLIN D1; MICRORNA; MICRORNA 638; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR SP2; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CELL ACTIVITY; CELL CYCLE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; CONTROLLED STUDY; G1 PHASE CELL CYCLE CHECKPOINT; HEK293 CELL LINE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LUCIFERASE ASSAY; MTT ASSAY; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH; STOMACH CANCER; WESTERN BLOTTING;

CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN D1; CYCLIN D2; DOWN-REGULATION; GENE KNOCKDOWN TECHNIQUES; HUMANS; MICRORNAS; SP2 TRANSCRIPTION FACTOR; STOMACH NEOPLASMS;

EID: 84905562436     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-014-3087-5     Document Type: Article

References (26)

1. Liu H, Zhu L, Liu B, et al. RGenome-wide microRNA profiles identify miR-378 as a serum biomarker for early detection of gastric cancer. Cancer Lett. 2012;316:196-203.
2. Parkin DM, Bray FI, Devesa SS. Cancer burden in the year 2000, the global picture. Eur J Cancer. 2001;37:S4-S66.
3. Yuasa Y. Control of gut differentiation and intestinal-type gastric carcinogenesis. Nat Rev Cancer. 2003;3:592-600. (Pubitemid 37328831)
4. Esquela-Kerscher A, Slack FJ. Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer. 2006;6:259-269.
5. Petrocca F, Visone R, Onelli MR, et al. E2F1-regulated microRNAs impair TGF beta-dependent cell-cycle arrest and apoptosis in gastric cancer. Cancer Cell. 2008;13:272-286. (Pubitemid 351318375)
6. Kim YK, Yu J, Han TS, et al. Functional links between clustered microRNAs: suppression of cell-cycle inhibitors by microRNA clusters in gastric cancer. Nucleic Acids Res. 2009;37:1672-1681.
7. Yao Y, Suo AL, Li ZF, et al. MicroRNA profiling of human gastric cancer. Mol Med Rep. 2009;2:963-970.
8. Black AR, Black JD, Azizkhan-Clifford J. Sp1 and Kruppel-like factor family of transcription factors in cell growth regulation and cancer. J Cell Physiol. 2001;188:143-160. (Pubitemid 32622905)
9. Kim TH, Chiera SL, Linder KE, et al. Overexpression of transcription factor sp2 inhibits epidermal differentiation and increases susceptibility towoundand carcinogen-induced tumorigenesis. Cancer Res. 2010;70:8507-8516.
10. Lu J, Getz G, Miska EA, et al. MicroRNA expression profiles classify human cancers. Nature. 2005;435:834-838. (Pubitemid 40839735)
11. Zhang F, Yang Z, Cao M, et al. MiR-203 suppresses tumor growth and invasion and down-regulates MiR-21 expression through repressing Ran in esophageal cancer. Cancer Lett. 2014;342:121-129.
12. Wada R, Akiyama Y, Hashimoto Y, et al. miR-212 is downregulated and suppresses methyl-CpG-binding protein MeCP2 in human gastric cancer. Int J Cancer. 2010;127:1106-1114.
13. Xia Y, Chen Q, Zhong Z, et al. Down-regulation of miR-30c promotes the invasion of non-small cell lung cancer by targeting MTA1. Cell Physiol Biochem. 2013;32:476-485.
14. Gopalan V, Pillai S, Ebrahimi F, et al. Regulation of microRNA-1288 in colorectal cancer : Altered expression and its clinicopathological significance. Mol Carcinog. 2013;53:E36-E44.
15. Lang Q, Ling C. MiR-124 suppresses cell proliferation in hepatocellular carcinoma by targeting PIK3CA. Biochem Biophys Res Commun. 2012;426:247-252.
16. Poudel S, Song J, Jin EJ, et al. Sulfuretin-induced miR-30C selectively downregulates cyclin D1 and D2 and triggers cell death in human cancer cell lines. Biochem Biophys Res Commun. 2013;431:572-578.
17. Budhu A, Jia HL, Forgues M, et al. Identification of metastasis related microRNAs in hepatocellular carcinoma. Hepatology. 2008;47:897-907. (Pubitemid 351449681)
18. Aravalli RN, Steer CJ, Cressman EN. Molecular mechanisms of hepatocellular carcinoma. Hepatology. 2008;48:2047-2063.
19. Rossi JJ. New hope for a microRNA therapy for liver cancer. Cell. 2009;137:990-992.
20. Li D, Wang Q, Liu C, et al. Aberrant expression of miR-638 contributes to benzo(a)pyrene-induced human cell transformation. Toxicol Sci. 2012;125:382-391.
21. Safe S, Abdelrahim M. Sp transcription factor family and its role in cancer. Eur J Cancer. 2005;41:2438-2448. (Pubitemid 41540621)
22. Wang L, Wei D, Huang S, et al. Transcription factor Sp1 expression is a significant predictor of survival in human gastric cancer. Clin Cancer Res. 2003;9:6371-6380. (Pubitemid 38031822)
23. Stoner M, Wormke M, Saville B, et al. Estrogen regulation of vascular endothelial growth factor gene expression in ZR-75 breast cancer cells through interaction of estrogen receptor a and Sp proteins. Oncogene. 2004;23:1052-1063. (Pubitemid 38269959)
24. Abdelrahim M, Smith R III, Burghardt R, et al. Role of Sp proteins in regulation of vascular endothelial growth factor expression and proliferation of pancreatic cancer cells. Cancer Res. 2004;64:6740-6749. (Pubitemid 39297937)
25. Phan D, Cheng CJ, Galfione M, et al. Identification of Sp2 as a transcriptional repressor of carcinoembryonic antigen-related cell adhesion molecule 1 in tumorigenesis. Cancer Res. 2004;64:072-078.
26. Kozar K, Ciemerych MA, Rebel VI, et al. Mouse development and cell proliferation in the absence of D-cyclins. Cell. 2004;118:477-491. (Pubitemid 39485667)